We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+41.78%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$642M
AUM Growth
+$187M
Cap. Flow
+$68M
Cap. Flow %
10.59%
Top 10 Hldgs %
58.84%
Holding
55
New
3
Increased
31
Reduced
11
Closed
–

Top Buys

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$20M
2
OMCL icon
Omnicell
OMCL
+$15.4M
3
HRTX icon
Heron Therapeutics
HRTX
+$11.6M
4
ARRY
Array Biopharma Inc
ARRY
+$11.4M
5
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$8.29M

Top Sells

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$34.8M
2
XNCR icon
Xencor
XNCR
+$4.68M
3
NVRO
NEVRO CORP.
NVRO
+$4.19M
4
GMED icon
Globus Medical
GMED
+$3.89M
5
HSTM icon
HealthStream
HSTM
+$3.45M

Sector Composition

Rank Sector Weight
1 Healthcare 84.94%
2 Communication Services 3.88%
3 Energy 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
26
BioMarin Pharmaceuticals
BMRN
$11.6B
$5.91M 0.92%
62,750
+30,900
+97% +$2.71M
QDEL icon
27
QuidelOrtho
QDEL
$1.14B
$5.37M 0.84%
80,755
+4,687
+6% +$283K
GMED icon
28
Globus Medical
GMED
$10.7B
$5.28M 0.82%
104,615
-74,649
-42% -$3.89M
BLUE
29
DELISTED
bluebird bio
BLUE
$5.24M 0.82%
2,575
+613
+31% +$1.4M
LHCG
30
DELISTED
LHC Group LLC
LHCG
$4.65M 0.72%
54,360
-17,639
-24% -$1.34M
NXTM
31
DELISTED
NxStage Medical Inc.
NXTM
$4.25M 0.66%
152,448
-40,891
-21% -$1.1M
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$121B
$4.25M 0.66%
24,974
+1,545
+7% +$239K
TLGT
33
DELISTED
Teligent, Inc
TLGT
$3.98M 0.62%
115,103
+5,021
+5% +$158K
KIDS icon
34
OrthoPediatrics
KIDS
$519M
$3.31M 0.51%
124,108
+7,923
+7% +$169K
HSTM icon
35
HealthStream
HSTM
$819M
$2.5M 0.39%
91,635
-130,033
-59% -$3.45M
STRM
36
DELISTED
Streamline Health Solutions
STRM
$2.43M 0.38%
114,944
-11,568
-9% -$264K
IBB icon
37
iShares Biotechnology ETF
IBB
$9.34B
$2.34M 0.36%
21,291
– –
XLVS
38
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$2.22M 0.35%
17,285
– –
SGMO
39
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.21M 0.34%
+155,348
New +$2.58M
LMAT icon
40
LeMaitre Vascular
LMAT
$2.32B
$1.67M 0.26%
49,996
+3,086
+7% +$110K
XLV icon
41
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.52M 0.24%
18,241
– –
IHI icon
42
iShares US Medical Devices ETF
IHI
$3.13B
$1.52M 0.24%
45,480
– –
IRIX icon
43
IRIDEX
IRIX
$14.3M
$1.38M 0.22%
198,581
-189,106
-49% -$1.21M
ALKS icon
44
Alkermes
ALKS
$8.22B
$1.33M 0.21%
32,271
+2,060
+7% +$93.8K
CELG
45
DELISTED
Celgene Corp
CELG
$1.17M 0.18%
14,742
+890
+6% +$73.9K
ENZ
46
DELISTED
Enzo Biochem, Inc.
ENZ
$984K 0.15%
189,600
-61,402
-24% -$374K
ABBV icon
47
AbbVie
ABBV
$443B
$385K 0.06%
4,159
– –
DYNT
48
DELISTED
Dynatronics Corp
DYNT
$313K 0.05%
21,777
+380
+2% +$5.59K
PFE icon
49
Pfizer
PFE
$143B
$310K 0.05%
9,020
– –
NVS icon
50
Novartis
NVS
$297B
$270K 0.04%
3,986
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, First Light Asset Management held 55 positions worth $642M, up 41% from $455M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

First Light Asset Management deployed $68M of net new capital in Q2 2018, opening 3 new positions and adding to 31 existing holdings. Its largest new stake was SANGAMO THERAPEUTICS INC: 155,348 shares worth $2.21M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 85% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $34.8M trimmed.

  • First Light Asset Management's largest Q2 2018 buy was SANGAMO THERAPEUTICS INC: 155,348 shares worth $2.21M.
  • First Light Asset Management added most to Ionis Pharmaceuticals in Q2 2018, an estimated $20M increase.
  • First Light Asset Management's biggest Q2 2018 reduction was Tandem Diabetes Care, cutting an estimated $34.8M.
  • First Light Asset Management's ten largest holdings make up 59% of its $642M portfolio in Q2 2018.
  • First Light Asset Management opened 3 new positions and closed 0 in Q2 2018.
  • First Light Asset Management's portfolio value rose 41% quarter-over-quarter to $642M.

Based on First Light Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.